HO-1 overexpression has been observed to be involved in the development of several types of cancer, including pancreatic and prostatic cancer, renal carcinoma, myeloma, and lung adenocarcinomas [18,19,20,21], and it has been widely associated with chemoresistance insurgence [22]. This evidence concerns the gene HMOX1 and cancer.